Yerevan
Tbilisi
Moscow
Paris
Los Angeles
Beijing
English
Հայերեն Русский
Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Timeline
Idram and IDBank Participated in the Opening of My Forest Armenia’s Pavilion at COP17Unibank Receives B++ Sustainability Alignment Rating from Agents for Impact GmbH Ucom Supported Yerevan Conservation Symposium 2026 as Strategic PartnerIDBank to Showcase Environmental and Innovative Initiatives at COP17New AI-Powered Wildlife Monitoring Camera Installed in Paruyr Sevak with the Support of Ucom35 Years of Trust: IDBank Celebrates with Its CustomersBusiness and mining leader Mark Cutifani to deliver keynote speech at the 3rd Mining Armenia Forum“From Classroom to Orbit”: With Ucom’s Support, “Space 1.0” Is Being Introduced in 15 Schools Across ArmeniaAfeyan Initiatives for Armenia Awards Grant to the Armenia Education Initiative to Expand the Teach For Armenia’s Seroond School Turnaround Program Ucom to Participate in COP17 Together with FPWC, Showcasing Their Environmental Partnership“The Golden Hour”: IDBank explains how to respond effectively to a scam attackNelli Kocharyan Presents Converse Bank’s Vision for Development of International Relations at the BACEE Conference BACEE International Conference Kicks Off with Converse Bank as Lead Sponsor Unibank has issued perpetual bonds with an annual coupon yield of 13.2% Ucom Measures the Environmental Impact of Its OperationsUnibank Offers USD-Denominated Bonds with an Annual Coupon Rate of 6% Ucom Becomes an Official Partner of the Armenia-UK Business Forum 2026Ucom Sales and Service Center at 20/52 Erebuni Reopens After Renovation Unibank Joins the Armenian Solar Energy AssociationThe Widely Discussed Dvin Crown Project. A New Visibility Platform for Brands Has Emerged in the Heart of Yerevan
All Timeline »
Life

Multiple sclerosis drug shows promising efficacy

The multiple sclerosis drug is showing promising efficacy in fighting relapses and reducing fatigue.

Back in March 2001, the US Food and Drug Administration approved a drug called ponosimod for use in adult patients with various types of multiple sclerosis. Only now there are research data that show that some drug reduces the number of relapses of the disease and can reduce fatigue - one of the characteristic symptoms of multiple sclerosis.

The respected scientific journal JAMA Neurology has found that ponesimod is more effective in fighting fatigue in multiple sclerosis than another commonly used drug called teriflunomide. It is superior to teriflunomide in reducing relapse rates and reducing the risk of new or existing lesions of myelin found on magnetic resonance imaging.

As reported by everydayhealth.com, ponesimod is used for various types of multiple sclerosis, including the most common relapsing remitting disease and active secondary progressive, which is the most severe. It is not accompanied by remissions and steadily leads to the disability of patients. It is people with this form of multiple sclerosis who show the appearance of new lesions of the myelin layer on MRI scans. Ponesimod must be taken once a day, treatment begins with a period of 14 days, then the doses are increased.